DK157033B - Reversible liquid/solid phase change agent and application thereof - Google Patents

Reversible liquid/solid phase change agent and application thereof Download PDF

Info

Publication number
DK157033B
DK157033B DK455882A DK455882A DK157033B DK 157033 B DK157033 B DK 157033B DK 455882 A DK455882 A DK 455882A DK 455882 A DK455882 A DK 455882A DK 157033 B DK157033 B DK 157033B
Authority
DK
Denmark
Prior art keywords
weight
cacl2
mixture
potassium
agent
Prior art date
Application number
DK455882A
Other languages
Danish (da)
Other versions
DK157033C (en
DK455882A (en
Inventor
George Ashel Lane
Harold Everett Rossow
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Priority to DK455882A priority Critical patent/DK157033C/en
Publication of DK455882A publication Critical patent/DK455882A/en
Publication of DK157033B publication Critical patent/DK157033B/en
Application granted granted Critical
Publication of DK157033C publication Critical patent/DK157033C/en

Links

Landscapes

  • Seasonings (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Description

DK 157033 BDK 157033 B

Opfindelsen angâr réversible væske/faststof-faseændringsmid-ler bestâende af CaCl2,6H20, et sait som forhindrer dannelsen af krystal1inske CaCl2~hydratfaser, som ikke er CaCl2»6H20, eventuelt et eller flere kimdannende stoffer og eventuelt et 5 eller flere natriumsalte og/eller strontiumsalte, og hvor den semikongruente smelteadfærd hos CaCl2,6H20 er tilnærmet den kongruente smelteadfærd hos en kongruent smeltende blanding, samt anvende!se af midlet som varmelegeringsmedium.The invention relates to reversible liquid / solid phase change agents consisting of CaCl2.6H2O, a site which prevents the formation of crystalline CaCl2 hydrate phases which are not CaCl2.6H2O, optionally one or more nucleating agents and optionally a 5 or more sodium salts and / or strontium salts, and wherein the semi-congruent melting behavior of CaCl2.6H2O is approximated to the congruent melting behavior of a congruent melting mixture, as well as using the agent as a heat alloying medium.

10 Faseændringsmateria 1er (PCM), hvori forskellige hydratiserede sa!tblandingers smeltevarme anvendes, er velkendte i littera-turen. I ASHRAE Journal fra september 1974, under titlen S0-LAR ENERGY STORAGE, bedemmer Dr. M. Telkes PCM's termiske, fysiske og andre relevante egenskaber pâ grundlag af ekonomi, 15 anvendelighed, korrosion, toksicitet og tiIgængelighed til anvendelse i installationer i stor mâlestok. Blandt de vurde-rede materialer var forskellige salthydrater og deres eutek-tika inklusive CaCl2,6H20, som undergàr flere faseovergange til materialer med forskellig krystalstruktur, dvs. CaCl2f6H20 20 til CaCl2/4H20 + 2H20 ved 29eC.Phase change materials (PCMs), in which the melt heat of various hydrated mixtures are used, are well known in the literature. In the September 1974 ASHRAE Journal, entitled S0-LAR ENERGY STORAGE, Dr. M. Telkes PCM's thermal, physical and other relevant properties on the basis of economy, applicability, corrosion, toxicity and accessibility for use in large scale installations. Among the evaluated materials were various salt hydrates and their eutics including CaCl2.6H2O, which undergoes multiple phase transitions for materials of different crystal structure, ie. CaCl2f6H2O20 to CaCl2 / 4H2O + 2H2O at 29 ° C.

Nâr saltet CaCl2,6H20 opvarmes til en temperatur over 33°C, oploses det fuldstændigt i sit krystalvand. Nâr det afkeles, er dannelse af fire forskellige krystalformer mulig, dvs.When the salt of CaCl2.6H2O is heated to a temperature above 33 ° C, it dissolves completely in its crystal water. When cooled, formation of four different crystal forms is possible, i.

25 CaCl2f6H20 og tre former af CaCl2,41^0. Hvis nogen af 4H2O-krystallerne dannes, er smeltevarmen meget mindre end 193 J/g (CaCl2/6H20 i hovedagelig ren form undergàr en faseovergang fra væske til fast stof ved ca. 30eC og friger eller alterna-tivt absorberer ca. 193 J/g. Til trods for den relativt lave 30 pris pâ CaCl2» blev dannelsen af dets fire forskellige kry-stalformer anset for at være en ulempe.And three forms of CaCl2.41 ^ 0. If any of the 4H 2 O crystals are formed, the heat of melting is much less than 193 J / g (CaCl 2/6 H 2 Despite the relatively low price of CaCl2, the formation of its four different crystal forms was considered to be a disadvantage.

Svensk patentskrift nr. 78.01037-8 (fremlæggelsesskrift nr. 410.004) omhandler en fremgangsmàde til at undertrykke tetra-35 hydratdannelsen under gentagen smeltning og krystal1isation af et System baseret pâ CaC^ei^O. Det viste sig, at i op-lesninger i koncentrationsintervallet fra 48 til 53 vægt%Swedish Patent Specification No. 78.01037-8 (disclosure no. 410,004) discloses a method of suppressing tetrahydrate formation during repeated melting and crystallization of a System based on CaCl3. It was found that in readings in the concentration range from 48 to 53% by weight

DK 157033 BDK 157033 B

22

CaCl2» under anvendelse af CaCl2,6H2Û af sterste renhed, var krystallsationstemperaturerne for CaCl2,6H20 og CaCl2,4H20 sâledes, at oplosningen smeltede inkongruent, og at CaCl2/4H2Û krystalliserede og udfældede af oplesningen og 5 derved mistede sin varmelagringskapacitet. Ved at anvende en oplesning med samme koncentration fremstillet ud fra CaCl2 af teknisk kvalitet (vejsalt) og indeholdende NaCl og KC1 som urenheder faldt opleseligheden af tetrahydratet, og oplose-ligheden af hexahydratet voksede. Ved gentagen smeltning og 10 krystal1isation bliver udfældningen betydelig, og systemet mister igen sin varmelagringskapacitet. Der kan derfor drages den slutning, at brugen af en teknisk kvalitet CaCl2 (vejsalt) resulterer i en dârligere virkning pà grund af en for-holdsvis stigning i tetrahydratdannelsen sammenlignet med et 15 System baseret pâ CaCl2 af haj renhed.CaCl2 using the highest purity CaCl2.6H2Û, the crystallization temperatures of CaCl2.6H2O and CaCl2.4H2O were such that the solution melted incongruently and that the CaCl2 / 4H2Û crystallized and precipitated from the solution, thereby losing its heat storage capacity. Using a solution of the same concentration prepared from technical grade CaCl2 (road salt) and containing NaCl and KCl as impurities, the solubility of the tetrahydrate decreased and the solubility of the hexahydrate increased. With repeated melting and crystallization, the precipitation becomes significant and the system loses its heat storage capacity again. It can therefore be concluded that the use of a technical grade CaCl2 (road salt) results in a poorer effect due to a relative increase in tetrahydrate formation compared to a shark purity CaCl2 system.

Det viste sig ogsà, at tilsætning af ên eller flere forbin-delser inklusive ca. 2 v*gt% SrCl2,6H20 foregede opleselighe-den af tetrahydatet og undertrykte tetrahydratdannelsen ved 20 gentagen smeltning og krystallisation. Ti1sætningsmængden vi-ste sig at vaere afhængig af den i systemet ti 1 stedeværende urenhedsmængdef som i et eksempel under anvendelse af vejsalt blev bestemt t i1 at være 2,2 vægt%.It was also found that the addition of one or more compounds including ca. 2% by weight of SrCl2.6H2O pretreated the solubility of the tetrahydrate and suppressed the tetrahydrate formation by repeated melting and crystallization. The amount of addition was found to be dependent on the amount of impurity present in the system as in an example using road salt was determined to be 2.2% by weight.

25 De relative mængder af hver urenhed i saltet af teknisk kvalitet (vejsalt) blev ikke bestemt, og de blev heller ikke an-set for at være af betydning for resultatet af de udferte forseg. Brugen af vejsalt viste sig faktisk at være mindre enskelig ud fra synspunktet tetrahydratdannelse sammenlignet 30 med CaCl2 af h0J renhed. Der var heller ingen erkendelse af, at urenheder af NaCl og KCl i mildet kunne være gavnlige t i1 at reducere tetrahydratkrystaldannelsen i sâdanne faseæn- dringsmidler.The relative amounts of each impurity in the technical grade (road salt) salt were not determined, nor were they considered to be of significance to the result of the tests performed. Indeed, the use of road salt was found to be less solitary from the point of view of tetrahydrate formation compared to CaCl2 of high purity. There was also no recognition that, in the mild, impurities of NaCl and KCl could be beneficial in reducing tetrahydrate crystal formation in such phase change agents.

35 I US patentskrift nr. 4.613.444 blev det vist, at tilsætning af KCl til CaCl2,6H2Û væsentligt reducerer muligheden for dannelse af den uonskede CaCl2,4H20-krystalfase under genvin-In U.S. Patent No. 4,613,444, it was shown that addition of KCl to CaCl2.6H2Û significantly reduces the possibility of forming the undesired CaCl2.4H20 crystal phase during recovery.

DK 157033 BDK 157033 B

3 ding af den lagrede varme ved frysning af faseændringsmid1 et.3 of the stored heat by freezing the phase change agent.

Det har nu ifelge den foreliggende opfindelse overraskende vist sig, at den enskede virkning af at reducere danne 1 se af den uonskede CaCl2,4H20-krystalfase ogsâ kan opnâs med andre 5 salte end chloridet, dvs. KC1 . Især kan reduktionen af dan-nelsen af CaCl2,4H20-krystalfasen under genvinding af den lagrede varme ved frysning af den hydratiserede CaC^-blan-ding opnâs ved tilsætning af et kaliumsalt, hvori det benyt-tede kaliumsalts anion danner et tungt opleseligt calcium-10 sait, dvs. et calciumsalt, som i ait væsentligt er uoplese-1 igt.It has now been found, surprisingly, in accordance with the present invention that the sole effect of reducing the formation of the unwanted CaCl2.4H2O crystal phase can also be obtained with other salts other than the chloride, i. KC1. In particular, the reduction of the formation of the CaCl2.4H2O crystal phase by recovering the stored heat by freezing the hydrated CaCl3 mixture can be achieved by the addition of a potassium salt in which the potassium salt of the used potassium forms a heavily soluble calcium salt. 10 seats, ie. a calcium salt which is substantially unresolved.

I US patentskrift nr. 4.613.444 vises ogsâ, at tilsætningen af NaCl og/eller SrCl2 foreger den fordelagtige virkning, der 15 fremkommer ved tilsætning af KC1 til den hydratiserede CaCl2“ blanding for derved at opnâ et effektivt kongruent smeltende middel. Det har nu vist sig, at andre natrium- og/eller strontiumsalte ogsâ kan anvendes med samme gunstige resulta-ter.U.S. Patent No. 4,613,444 also discloses that the addition of NaCl and / or SrCl2 exacerbates the beneficial effect of adding KCl to the hydrated CaCl2 mixture to obtain an effective congruent melting agent. It has now been found that other sodium and / or strontium salts can also be used with the same favorable results.

2020

Til nogle anvendelser foretrækkes det f.eks. at anvende kalium-, natrium- eller strontiumsalte eller blandinger af sâ-danne salte fremfor salte, hvor anionen er chlorid, for at hæve pH-værdien af blandingen og derved reducere den natur-25 lige surhed af vandig CaCl2· I systemer, dvs. faseændrings-midler, hvori kalium-, natrium- og strontiumsaltes anioner danner et væsentligt mindre oploseligt sait med calcium, for-bedres for!igelighed med varmelagringsmidlets metalbeholdere betydeligt.For some applications, it is preferred, for example. using potassium, sodium or strontium salts or mixtures of such salts rather than salts where the anion is chloride, to raise the pH of the mixture and thereby reduce the natural acidity of aqueous CaCl phase change agents, in which the anions of potassium, sodium and strontium salts form a substantially less soluble site with calcium, significantly improve compatibility with the metal containers of the heat storage agent.

3030

Varmelagringsmidler emballeres ideelt i individuelle indkaps-lingsmidler til brug i forbindelse med solvarmesystemer. Eksempler pâ egnede kendte indkapslingsmidler til de her om-handlede varmelagringsmidler er vanduigennemtrængelige film 35 eller folier af plast/metallaminater. Der har ogsâ været foreslàet plastskum med lukkede celler, hvori PCM kan være indkapslet i skumstrukturens celler, som f.eks. illustreret i 4Heat storage agents are ideally packaged in individual encapsulants for use in conjunction with solar heating systems. Examples of suitable known encapsulants for the heat storage agents disclosed herein are water-impermeable films 35 or sheets of plastic / metal laminates. Also, closed-cell plastic foam has been proposed in which PCM may be encapsulated in the foam structure cells, such as e.g. illustrated in 4

DK 157033 BDK 157033 B

amerikansk patentskrift nr. 4.003.426. André nyttige indkaps-lingsmidler er béton, métal eller plastbeholdere, ror og lig-nende.U.S. Patent No. 4,003,426. Other useful encapsulants are concrete, metal or plastic containers, rudders and the like.

5 Opfindelsen angàr et reversibelt væske/faststof-faseændrings-middel af den i indledningen nævnte art, som er ejendommeligt ved af 37-51 vægt% CaCl2 er blandet med 0,5-26 vægt% af et kaliumsalt, hvis anion danner et sait med calcium som er væ-sentligt mindre opleseligt end CaCl2, og med resten af blan-10 dingen H2O op til 100%.The invention relates to a reversible liquid / solid phase change agent of the kind mentioned in the preamble, which is characterized by 37-51% by weight CaCl2 mixed with 0.5-26% by weight of a potassium salt whose anion forms a site with calcium which is substantially less soluble than CaCl2, and with the remainder of the mixture H2O up to 100%.

Opfindelsen angâr endvidere anvendelsen af det nævnte middel som varmelagringsmedium.The invention further relates to the use of said agent as heat storage medium.

15 Selv om den hydratiserede CaCl2/kaliumsaltblanding ifelge opfindelsen overraskende formindsker dannelsen af andre kry-stalformer end hexahydratformen, viste det sig, at den sta-dig bevarede de iboende karakteristika ved CaCl2,6H20's un-derafkelingsegenskaber. Opfindelsen tager derfor fortrinsvis 20 sigte pâ tilsætning af udvalgte krystalkimdannende midler til effektiv formindskelse af underafkeling i det hydratiserede CaCl2/kali umsaltSystem.Although the hydrated CaCl2 / potassium salt blend according to the invention surprisingly diminishes the formation of crystal forms other than the hexahydrate form, it was found that it still retained the inherent characteristics of the CaCl2.6H2O decay properties. Therefore, the invention is preferably directed to the addition of selected crystal nucleating agents to effectively reduce sub-precipitation in the hydrated CaCl2 / potassium salt system.

Undgàelsen af underafkoling under krystallisationen af hydra-25 tiseret CaCl2, f.eks. ved tilsætning af forskellige kimdan-nende midler, er almindeligt kendt i 1itteraturen, f.eks. fra U.S.S.R. opfindercertifikat nr. 568.669, Japansk patenskrift nr. 969.909, og US patentskrift nr. 4.189.394. Kimdannende midler var dog ikke beregnet som additiver til opnâelse af 30 kongruent smeltende sa!thydrater.The avoidance of undercooling during the crystallization of hydrated CaCl2, e.g. by the addition of various nucleating agents is well known in the literature, e.g. from the U.S.S.R. Inventor Certificate No. 568,669, Japanese Patent No. 969,909, and U.S. Patent No. 4,189,394. However, nucleating agents were not intended as additives to obtain 30 congruent melting hydrates.

Selv ved tilsætning af et kaliumsalt, hvori anionen er til stede i en tiIstrækkelig mængde til effektivt at reducere faseændringsmidlets tendens til ved frysning at danne den 35 uonskede fase CaCl2,4H20, er selv en ved oplosel ighedsgræn-sen maksimal ti1stedeværende mængde ikke tiIstrækkelig til fuldstændigt af forhindre dannelsen af CaCl2#4H20. I en fore-Even with the addition of a potassium salt in which the anion is present in a sufficient amount to effectively reduce the tendency of the phase change agent to form, by freezing, the unwanted phase CaCl2.4H2O, even a maximum amount present at the solubility limit is not sufficient to fully of preventing the formation of CaCl2 # 4H20. In a

DK 157033 BDK 157033 B

5 trukken udforelsesform for opfindelsen kan i overensstemmel-se hermed det dannede CaCl2/4H20 fulstændingt forhindres i at krystallisere, hvis kaliumsaltet anvendes i kombination med et natrium- og/eller strontiumsalt, hvori anionen danner et 5 væsentligt mindre oploseligt sait med calcium.Accordingly, the embodiment of the invention can be completely prevented from crystallizing if the potassium salt is used in combination with a sodium and / or strontium salt in which the anion forms a substantially less soluble site with calcium.

Den foreliggende opfindelse repræsenterer et betydeligt frem-skridt i retning mod udvikling af et billigt, men meget ef-fektivt reversibelt væske/faststof-faseændringsmiddel baseret 10 pâ hydratiseret CaCl2 i blanding med et kaliumsalt.The present invention represents a significant step toward the development of an inexpensive but highly effective reversible liquid / solid phase change agent based on hydrated CaCl 2 in admixture with a potassium salt.

Faseændringsmaterialer pâ basis af hydratiseret sait udviser tre almene typer faseændringsadfærd: Kongruent, semi-kongru-ent og inkongruent smeltning. Den mest anskelige adfærd er 15 kongruent smeltning, der forekommer, nâr det faste faseæn-dringsmiddel (forhold mellem sait og bundet vand) er det sam-me som det flydende fasemiddel. I det tilfælde forekommer hy-dratisering/dehydrastiseringsprocessen at være identisk med smelte- og fryseprocessen.Hydrated site phase change materials exhibit three general types of phase change behavior: congruent, semi-congruent, and incongruent melting. The most desirable behavior is 15 congruent melting that occurs when the solid phase change agent (ratio of sait to bound water) is the same as the liquid phase agent. In that case, the hydration / dehydration process appears to be identical to the melting and freezing process.

2020

Udtrykket "effektivt kongruent smeltende blanding" som heri benyttet definerer en blanding af bestanddele pâ basis af vandigt calciumchlorid, for hvilken faste og flydende faser er i stabil ligevægt ved smeltepunktet. Den faste fase inde-25 holder intet hydratiseret calciumchloridmateriale udover hexahydratet eller faste oplasninger deraf, og den flydende fase indeholder for hvert mol calciumchlorid 6 mol vand plus ti Istrækkeligt meget vand til dannelse af det stabile hydrat af hvilke som helst tilsatte materialer i oplosning.The term "effective congruent melt blend" as used herein defines a blend of aqueous calcium chloride constituents for which solid and liquid phases are in stable equilibrium at the melting point. The solid phase contains no hydrated calcium chloride material other than the hexahydrate or solid solutions thereof, and for each mole of calcium chloride the liquid phase contains 6 moles of water plus ten sufficient water to form the stable hydrate of any added materials in solution.

3030

Semi-kongruent smeltning forekommer, nâr et faseændringsmate-riale har to eller flere hydratformer med forskellige fast-stofsammensætninger og smeltepunkter. Materialet kan omdannes til andre hydratformer, for der sker enten fuldstændig smelt-35 ning eller frysning, hvilket resulterer i et udvidet smelte-punktsinterval. Desuden er der et midlertidigt tab i varme-lagringskapacitet. Calciumchloridhexahydrat er et eksempel pâ et semikongruent smeltende faseændringsmateriale.Semi-congruent melting occurs when a phase change material has two or more hydrate forms with different solids compositions and melting points. The material can be converted to other hydrate forms for either complete melting or freezing, resulting in an extended melting point range. In addition, there is a temporary loss in heat storage capacity. Calcium chloride hexahydrate is an example of a semi-congruent melting phase change material.

66

DK 157033 BDK 157033 B

Inkongruent smeltende faseændringsmaterialer danner to tyde-ligt adskilte faser ved smeltning: En mættet oplosning og et præcipitat af et uoploseligt vandfrit sait. Hvis præcipita-tet fælder ud af opl0sningen, vil det vandfri sait ikke hy-5 dratisere fuldstændigt ved afk0ling, og nogen varmelagrings-kapacitet vil gâ tabt ved hver fryse/smeltecyklus. Inkongru-ent smeltning, som iagttages med f.eks. natriumsulfatdecahy-drat, er et mere alvorligt problem, fordi det kan resultere i et vedvarende tab af latent varmelagringskapacitet.Incongruent melting phase change materials form two distinctly distinct phases of melting: a saturated solution and a precipitate of an insoluble anhydrous site. If the precipitate falls out of solution, the anhydrous site will not completely hydrate upon cooling and any heat storage capacity will be lost with each freeze / melt cycle. Incongruent melting observed with e.g. sodium sulfate decahydrate, is a more serious problem because it can result in a sustained loss of latent heat storage capacity.

1010

Udtrykket "underafk0ling" refererer til en forskel mellem den temperatur, ved hvilken frysning begynder, og smeltetempera-turen af et givet væske/faststof-faseændringsmateriale, nâr det afkoles og opvarmes under rolige betingelser.The term "undercooling" refers to a difference between the temperature at which freezing begins and the melting temperature of a given liquid / solid phase change material when cooled and heated under calm conditions.

1515

Udtrykket "additiver" indbefatter foruden kimdannende midler, som inærmere specificeret i det felgende, forstadier for sâ-denine additiver» som ikke er skadelige for funktonen af fa-seændringsmaterialer ifolge opfindelsen. De heri omtalte ad- 20 ditiver er nærmere betegnet enten vandfrie eller hydratise-rede saromensætninger af uorganiske salte eller forstadiemate-rialer, som ville danne saltet ved tilsætning til hydratise-ret calciumchlorid.The term "additives" includes, in addition to nucleating agents, as specified in the following, precursors for such additives which are not detrimental to the operation of phase change materials according to the invention. More particularly, the additives mentioned herein are either anhydrous or hydrated sarcoma compositions of inorganic salts or precursor materials which would form the salt upon addition of hydrated calcium chloride.

25 Midlet ifolge opfindelsen omfatter som nævnt en blanding af fra 37 til 51 vægt% CaCl2 og fra 0,5 til 26 vægt% kaliumsalt, idet resten er H2O (i en mængde op til 100 vægt%). Eksempler pâ kaliumsalte er folgende: 30 Kaliumarsenat, kaliummetaborat, kaliumcitrat, kaliumf1uorid, kaliumhydroxid, kaliummolybdat, kaliumoxalat, kaliummetaphos-phat, kaliumpyrophosphat, kaliumsi1icat, kaliumsulfit og ka-1i umtartrat.The agent of the invention comprises, as mentioned, a mixture of from 37 to 51 wt% CaCl 2 and from 0.5 to 26 wt% potassium salt, the remainder being H 2 O (in an amount up to 100 wt%). Examples of potassium salts are as follows: Potassium arsenate, potassium metaborate, potassium citrate, potassium fluoride, potassium hydroxide, potassium molybdate, potassium oxalate, potassium metaphosphate, potassium pyrophosphate, potassium sulfate, potassium sulfite and potassium sulfate.

35 Kaliumsaltet sættes fortrinsvis til det hydratiserede CaCl2» sà at kaliumionen er til stede i en mængde fra 0,2 til 4,2' vægt% af blandingen.Preferably, the potassium salt is added to the hydrated CaCl 2 so that the potassium ion is present in an amount of 0.2 to 4.2% by weight of the mixture.

77

DK 157033 BDK 157033 B

Blandt de ovenfor nævnte kaliumsalte foretrækkes kaliumsul-fat, kaliumcarbonat og kaliumphosphat. Disse salte forelig-ger i et middel, hvori CaCl2 udger fra 37 til 51 vægt%. Kali-umsulfat blandes med CaCl2 i en mængde fra 0,5 til 19 vægt%, 5 kal iumcarbonat blandes med CaCl2 i en mængde fra 0,5 til 15 vægt%, og kaliumphosphat blandes med CaCl2 i en mængde fra 0,5 til 23 vægt%, idet resten i hvert tilfælde er vand i en mængde op til 100 vægt%.Among the above mentioned potassium salts, potassium sulphate, potassium carbonate and potassium phosphate are preferred. These salts are present in an agent in which CaCl 2 is from 37 to 51% by weight. Potassium sulphate is mixed with CaCl2 in an amount of 0.5 to 19% by weight, 5 potassium carbonate is mixed with CaCl2 in an amount of 0.5 to 15% by weight, and potassium phosphate is mixed with CaCl2 in an amount of 0.5 to 23 % by weight, the remainder being water in each case up to 100% by weight.

10 Eksempler pâ mest foretrukne faseændringsmidler er felgnde:Examples of most preferred phase change agents are the following:

CaCl2 - fra 47,1 til 50 vægt% K2SO4 - fra 8,4 til 10,8 vægt% H2O - resten op til 100 vægt% 15CaCl2 - from 47.1 to 50% by weight K2SO4 - from 8.4 to 10.8% by weight H2O - the remainder up to 100% by weight 15

CaCl2 - fra 47,5 til 50 vægt% K2CO3 - fra 8,7 til 10,6 vægt% H20 - resten op til 100 vægt% 20 CaCl2 - fra 48,5 til 50 vægt% K3PO4 - fra 7,6 til 9,1 vægt% H2O - resten op til 100 vægt%.CaCl2 - from 47.5 to 50% by weight K2CO3 - from 8.7 to 10.6% by weight H2 O - the residue up to 100% by weight CaCl2 - from 48.5 to 50% by weight K3PO4 - from 7.6 to 9, 1 wt% H2O - the residue up to 100 wt%.

I en foretrukken anvendelse indbefatter faseændringsmidlet 25 ogsà tilsætning af et natrium- og/eller strontiumsalt for yderligere at modificere CaCl2/6H20/kaliumsalt-blandingen for derved at opnâ et middel, som effektivt er et kongruent smel-tende middel.In a preferred application, the phase change agent 25 also includes the addition of a sodium and / or strontium salt to further modify the CaCl 2/6 H 2 O / potassium salt mixture to thereby obtain an agent which is effectively a congruent melting agent.

30 Natriumsaltet sætte fortrinsvis til det hydratiserede CaCl2f sà at natriumionen er til stede i en mængde fra 0,04 til 2,0 vægt% af midlet.The sodium salt preferably adds to the hydrated CaCl2f such that the sodium ion is present in an amount of 0.04 to 2.0% by weight of the agent.

Strontiumsaltet sættes fortrinsvis til det hydratiserede 35 CaCl2/ sâ at strontiumionen er til stede i en mængde fra 0,05 til 2,0 vægt% af midlet.The strontium salt is preferably added to the hydrated CaCl 2 / so that the strontium ion is present in an amount of 0.05 to 2.0% by weight of the agent.

DK 157033 BDK 157033 B

88

Eksempler pà natrium- og strontiumsalte er fclgende: natriumarsenat, natriummetaborat, natriumcitrat, natriumfluo-rid, natriumhydroxid, strontiumhydroxid, natriummolybdat, na-triumoxalat, natriummetaphosphat, natriumpyrophosphat, natri-5 umsilicat, natriumsu1fit, natriumtartrat og strontiumtartrat. Blandinger af disse salte kan ogsà anvendes.Examples of sodium and strontium salts are the following: sodium arsenate, sodium metaborate, sodium citrate, sodium fluoride, sodium hydroxide, strontium hydroxide, sodium molybdate, sodium oxalate, sodium metaphosphate, sodium pyrophosphate, sodium pyrophosphate, sodium 5 Mixtures of these salts can also be used.

Effektive mængder af de udvalgte krystalkimdannende midler for den hydratiserede CaCl2/kaliumsaltblanding ifclge opfin-10 delsen bestemmes ved at afprove en given sammensætning gennem gentagne faseændringscykler og pà en màde svarende til proce-durerne beskrevet i US patentskrift nr. 4.613.444. De deri omhandlede kimdannende midler har vist sig at ti1vejebringe tilsvarende udtalte fordele i CaCl2/kaliumsalt-systemet ifcl-15 ge den foreliggende opfindelse. Et kimdannende middel i en mængde pâ mere end ca. 2,0 vægt% af blandingens vægt tilveje-bringer ikke nogen forcget fordel, og folgelig foreligger det kimdannende middel fortrinsvis i en mængde fra 0,005 til 2,0 vægt%, beregnet pâ den totale vægt til formindskelse af un-20 derafko!ingen til 5°C eller mindre under genvinding af den ved hjælp af krystallisation lagrede varme. Det kimdannende middel er mere foretrukket til stede i en mængde fra 0,10 til 1,0 vægt%.Effective amounts of the selected crystal nucleating agents for the hydrated CaCl 2 / potassium salt mixture according to the invention are determined by testing a given composition through repeated phase change cycles and in a manner similar to the procedures described in U.S. Patent No. 4,613,444. The nucleating agents disclosed therein have been found to provide similarly pronounced advantages in the CaCl2 / potassium salt system of the present invention. A nucleating agent in an amount of more than approx. 2.0 wt% of the weight of the mixture does not provide any added benefit, and thus the nucleating agent is preferably present in an amount of 0.005 to 2.0 wt%, based on the total weight to reduce undercooking. 5 ° C or less while recovering the heat stored by crystallization. The nucleating agent is more preferably present in an amount of 0.10 to 1.0% by weight.

25 Kimdannende midler, som har vist sig at være særlig fordelag-tige i CaCl2/kaliumsalt-blandingen ifelge opfindelsen, er Ba(0H)2 / BaO, Bal2» 63^203, BaCOg, BaCl2, BaF2, BaF2,HF, Sr(0H)2, SrO, SrC03» SrF2, Srl2 eller blandinger deraf. Kimdannende midler valgt blandt BaCÛ3, BaCl2, BaO, Ba(0H)2» 30 Bal2, BaSÛ4, Sr(0H)2r SrO eller blandinger deraf foretrækkes.Nucleating agents which have been found to be particularly advantageous in the CaCl2 / potassium salt mixture of the invention are Ba (OH) 2 / BaO, Bal2 »63 ^ 203, BaCOg, BaCl2, BaF2, BaF2, HF, Sr ( OH) 2, SrO, SrCO3 »SrF2, Srl2 or mixtures thereof. Germination agents selected from BaCl3, BaCl2, BaO, Ba (OH) 2 »30 Bal2, BaS Ba4, Sr (OH) 2r SrO or mixtures thereof are preferred.

Urenheder kan forefindes i faseændringsmaterialet i mindre mængder pâ under ca. 3,0 vægt%, forudsat at disse urenheder ikke har nogen skadelig virkning pà funktionen af de grund-35 læggende hydratiserede CaCl2/kaliumsalt-faseændringsmidler ifolge opfindelsen, der kan indeholde de nedenfor omtalte kimdannnede midler og additiver, sâsom et natrium- og/ellerImpurities may be present in the phase change material in smaller amounts of less than approx. 3.0% by weight, provided that these impurities have no detrimental effect on the function of the basic hydrated CaCl2 / potassium salt phase change agents of the invention, which may contain the nucleating agents and additives mentioned below, such as a sodium and / or

DK 157033 BDK 157033 B

9 strontiumsalt. Urenheder kan f.eks. indbefatte LiCl, MgCl2 eller andre calciumsalte, sâsom CaC03 eller CaS04·9 strontium salt. Impurities may e.g. include LiCl, MgCl2 or other calcium salts, such as CaCO3 or CaSO4

De f0lgende eksempler illustrerer effektiviteten af et kali-5 umsalt, hvis anion danner et væsentligt mindre oploseligt sait med calcium, til at undertrykke dannelsen af uenskede hydrater i CaCl2,6H20/ka1iumsalt-faseændringsmidlerne ifelge opfindelsen.The following examples illustrate the effectiveness of a potassium salt, whose anion forms a substantially less soluble calcium site, to suppress the formation of undesired hydrates in the CaCl2.6H2O / potassium salt phase altering agents of the invention.

10 I eksempel 4 i US patentskrift nr. 4.613.444 blev det vist, at ved et H2O:CaCl2-molforhold pâ 6:1, uden additiver, smel-ter tetrahydratet ved 32,8°C og hexahydratet ved 29,6°C. I 3,2e C-omrâdet mellem disse to temperaturer kan CaCl2,4H20 derfor krystalliseres under fryseprocessen. I de felgende 15 eksempler blev forskellige kaliumsalte sat til vandige CaCl2~ oplesninger i tilstrækkelig mængde til mætning af oplesningen med kaliumioner, og virkningen blev bestemt pâ tetrahydrat-og hexahydratsmeltepunkterne.In Example 4 of U.S. Patent No. 4,613,444, it was shown that at a H2O: CaCl2 molar ratio of 6: 1, without additives, the tetrahydrate melts at 32.8 ° C and the hexahydrate at 29.6 ° C . Therefore, in the 3.2 C range between these two temperatures, CaCl 2,4 H 2 O can be crystallized during the freezing process. In the following 15 examples, various potassium salts were added to aqueous CaCl 2 solutions in sufficient quantity to saturate the solution with potassium ions and the effect was determined at the tetrahydrate and hexahydrate melting points.

2020

Eksempel 1.Example 1.

29,5 g blev sat til 500 g af en omr0rt opl0sning af 47% CaCl2 og 53% H2O. Denne f0rste blanding blev opvarmet til 60°C, langsomt afk01et til 23,8°C, podet med et krystal 2 5 af CaCl2r6H20 og fik lov til at komme i ligevægt. Et koncentrat blev ogsâ fremstillet ved tilsætning af 31,9 g K2S04 til 569,7 g af en opl0sning af 55% CaC^ og 45% H2O og opvarmning til 55°C. Dette koncentrat blev trinvis sat til den f0rste blanding i gradvis stigende mængder pâ 3 0 70-150 g , idet man lod ligevægt genetableres efter hver tilsætning. F0r hver tilsætning blev ligevægtstemperaturen 3529.5 g was added to 500 g of a stirred solution of 47% CaCl2 and 53% H2O. This first mixture was heated to 60 ° C, slowly cooled to 23.8 ° C, seeded with a crystal of CaCl2r6H2O and allowed to equilibrate. A concentrate was also prepared by adding 31.9 g of K 2 SO 4 to 569.7 g of a solution of 55% CaCl 2 and 45% H 2 O and heating to 55 ° C. This concentrate was gradually added to the first mixture in progressively increasing amounts of 30 to 70 g, equilibrating after each addition. Before each addition, the equilibrium temperature was 35

DK 157033 BDK 157033 B

10 bestemt, og en lille pr0ve af væskefasen blev taget fra og analyseret. Disse data vis te, at ved et ^OrCaC^-molfor-hold pâ 6:1 er CaC^fôI^O's smeltepunkt 27/1°C. Yderligere trinvis voksende tilsætninger af koncentratet bevirkede, at 5 hexahydratkrystallerne ændredes til alfa-tetrahydratkrystal-ler. Data opnâet fra disse tilsætninger viste, at ved et ^OiCaC^-molforhold pâ 6:1 er CaC^^I^O's smeltepunkt 29°C.10 and a small sample of the liquid phase was taken and analyzed. These data show that, at a 6 OrCaC molar ratio of 6: 1, the CaCl 2 melting point is 27/1 ° C. Further incremental additions of the concentrate caused the 5 hexahydrate crystals to be changed to alpha-tetrahydrate crystals. Data obtained from these additions showed that at a O OiCa C

Eksempel 2.Example 2.

10 pâ samme mâde som i eksempel 1 sattes 23 g til 500 g af en omr0rt opl0sning af 50% CaCl2 og 50% ï^O. Koncentratet indeholdt 17,7 g °9 385 9 af en opl0sning af 55%In the same manner as in Example 1, 23 g to 500 g of a stirred solution of 50% CaCl 2 and 50% 10 O were added. The concentrate contained 17.7 g ° 9 385 9 of a solution of 55%

CaCl2 og 45% H2O. De opnâede data viste, at ved et I^C^CaC^-molforhold pâ 6:1 er CaC^^E^O's smeltepunkt 27,0°C, og 15 CaC^ji^O's smeltepunkt er 28,0°C.CaCl2 and 45% H2O. The obtained data showed that at a 1 C, Ca 2 O molar ratio of 6: 1, the CaCl 2 E 2 O melting point is 27.0 ° C and the 15 CaC 2 E 2 O melting point is 28.0 ° C.

Eksempel 3.Example 3

Pâ samme mâde som i eksempel 1 og 2 sattes 23,6 g K3PC>4 til 503,7 g af en omr0rt opl0sning af 49,6% CaC^ og 50,4% I^O. Koncentratet indeholdt 35,6 g K3P04 i 759 g af en opl0sning 20 af 55% CaCl2 og 45% H20. Data viste, at ved et E^CkCaC^-molforhold pâ 6:1 er CaC^/ô^O' s smeltepunkt omtrent 27,8°C, og CaC^fi^O's smeltepunkt er 30,1°C.In the same manner as in Examples 1 and 2, 23.6 g of K3PC> 4 were added to 503.7 g of a stirred solution of 49.6% CaCl 2 and 50.4% I₂O. The concentrate contained 35.6 g of K3 PO4 in 759 g of a solution 20 of 55% CaCl2 and 45% H2 O. Data showed that at an E ^CkCaC ^ molar ratio of 6: 1, the CaC ^ / O₂O melting point is about 27.8 ° C, and the CaC₂ fiF ^O melting point is 30.1 ° C.

Nedenstâende tabel sammenfatter disse fors0g. De viser, at tilsætning af ^SO^, K2C03 eller K3P04 reducerer tempera-25 turintervallet, inden for hvilket CaCl2,4H20 er stabilt og sâledes formindsker tendensen til dannelse af denne u0nske-de krystallinske fase under fryseprocessen.The following table summarizes these attempts. They show that the addition of 2 SO 2, K 2 CO 3 or K 3 PO 4 reduces the temperature range within which CaCl 2,4 H 2 O is stable and thus decreases the tendency to form this undesirable crystalline phase during the freezing process.

DK 157033 BDK 157033 B

1.11.1

TabelTable

Virkning af kaliumsalte pâ calciumchloridhydrateraEffect of potassium salts on calcium chloride hydrates

CaCl2,4H20 CaCl2,6H20 CaCl2,4H20 Sait_Smp « °C_Smp. °C_Stabilt omrâdeCaCl2.4H20 CaCl2.6H20 CaCl2.4H20 Sait_Smp «° C_Smp. ° C_Stable range

intetb 32,8 29,6 3,2°Cnetb 32.8 29.6 3.2 ° C

K2S04 29,1 27,1 2,0°CK 2 SO 4 29.1 27.1 2.0 ° C

K2C03 28,0 27,0 1,0°CK 2 CO 3 28.0 27.0 1.0 ° C

K3P04 30,1 27,8 2,3°CK3 PO4 30.1 27.8 2.3 ° C

a - H20:CaCl2-molforhold = 6:1 5 b - ikke et eksempel if0lge opfindelsen smp. - smeltepunkt.a - H2O: CaCl2 mole ratio = 6: 1 b - not an example of the invention m.p. - melting point.

Claims (8)

1. Reversibelt væske/faststof-faseændringsmiddel bestàende af1. Reversible liquid / solid phase change agent consisting of 2. Middel ifolge krav 1, kendetegnet ved, at kali-umsaltet er sat til det hydratiserede CaCl2 i en sâdan mæng-de, at kaliumionen er til stede i en mængde fra ca. 0,2 til ca. 4,2 vægt% af blandingen. 202. An agent according to claim 1, characterized in that the potassium salt is added to the hydrated CaCl 2 in an amount such that the potassium ion is present in an amount of approx. 0.2 to approx. 4.2% by weight of the mixture. 20 3. Middel ifolge krav 1, kendetegnet ved, at kali-umsaltet er K2SO4, og at blandingen indeholder fra 37 til 51 vægt% CaCl2 og fra 0,5 til 19 vægt% K2SO4, idet resten af blandingen er H2O (op til 100 vægt%). 253. An agent according to claim 1, characterized in that the potassium salt is K2SO4 and the mixture contains from 37 to 51% by weight CaCl2 and from 0.5 to 19% by weight K2SO4, the remainder of the mixture being H2O (up to 100% by weight). %). 25 4. Middel ifolge krav 1 eller 2, kendetegnet ved, at kaliumsaltet er K2CO3, og at blandingen indeholder fra 37 til 51 vægt% CaCl2 og fra 0,5 til 15 vægt% K2CO3, idet resten af blandingen er H2O (op til 100 vægt%). 30An agent according to claim 1 or 2, characterized in that the potassium salt is K2CO3 and the mixture contains from 37 to 51% by weight CaCl2 and from 0.5 to 15% by weight K2CO3, the remainder of the mixture being H2O (up to 100% by weight). %). 30 5. Middel ifolge krav 1 eller 2, kendetegnet ved, at kaliumsaltet er K3PO4, og at blandingen indeholder fra 37 til 51 vægt% CaCl2 og fra 0,5 til 23 vægt% K3PO4, idet resten af blandingen er H2O (op til 100 vægt%). 35Agent according to claim 1 or 2, characterized in that the potassium salt is K3PO4 and the mixture contains from 37 to 51% by weight CaCl2 and from 0.5 to 23% by weight K3PO4, the remainder of the mixture being H2O (up to 100% by weight). %). 35 5 CaCl2/6H20, et sait som forhindrer dannelsen af krystal1inske CaCl2-hydratfaser, som ikke er CaCl2/6H2Û, eventuelt et eller flere kimdannende stoffer og eventuelt et eller flere natri-umsalte og/eller strontiumsalte, og hvor den semikongruente smelteadfærd hos CaCl2,6H20 er tilnærmet den kongruente smel-10 teadfærd hos en kongruent smeltende blanding, kende-t e g n e t ved, at 37-51 vægt% CaCl2 er blandet med 0,5-26 vægt% af et kaliumsalt, hvis anion danner et sait med calcium, som er væsentligt mindre oploseligt end CaCl2i og med resten af blandingen H2O op til 100%. 15CaCl2 / 6H2O, a site which prevents the formation of crystalline CaCl2 hydrate phases which are not CaCl2 / 6H2Û, optionally one or more nucleating agents and optionally one or more sodium salts and / or strontium salts, and wherein the semi-congruent melting behavior of CaCl2, 6H2O is approximated to the congruent melting behavior of a congruent melting mixture, characterized in that 37-51% by weight of CaCl2 is mixed with 0.5-26% by weight of a potassium salt whose anion forms a site with calcium, which is substantially less soluble than CaCl2i and with the remainder of the mixture H2O up to 100%. 15 6. Middel ifolge et eller flere af de foregâende krav, kendetegnet ved, at det kimdannende middel er valgt blandt Ba(0H)2, BaO, Bal2, BaS04, BaC03 og BaCl2· DK 157033 BAgent according to one or more of the preceding claims, characterized in that the nucleating agent is selected from Ba (OH) 2, BaO, Bal2, BaSO4, BaCO3 and BaCl2 · DK 157033 B 7. Middel ifolge krav 6, kendetegnet ved, at det eller de kernedannede midler er anvendt i en mængde pâ fra 0,005 til 2,0 vægt%.An agent according to claim 6, characterized in that the nucleated agent (s) is used in an amount of from 0.005 to 2.0% by weight. 8. Anvendelse af midlet ifolge et hvilket som helst af de foregâende krav som et varme1agringsmedium. 10 15 20 25 30 35Use of the agent according to any one of the preceding claims as a heat storage medium. 10 15 20 25 30 35
DK455882A 1982-10-14 1982-10-14 REVERSIBLE LIQUID / SOLID PHASE CHANGE AND USE THEREOF DK157033C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK455882A DK157033C (en) 1982-10-14 1982-10-14 REVERSIBLE LIQUID / SOLID PHASE CHANGE AND USE THEREOF

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK455882 1982-10-14
DK455882A DK157033C (en) 1982-10-14 1982-10-14 REVERSIBLE LIQUID / SOLID PHASE CHANGE AND USE THEREOF

Publications (3)

Publication Number Publication Date
DK455882A DK455882A (en) 1984-04-15
DK157033B true DK157033B (en) 1989-10-30
DK157033C DK157033C (en) 1990-04-02

Family

ID=8134627

Family Applications (1)

Application Number Title Priority Date Filing Date
DK455882A DK157033C (en) 1982-10-14 1982-10-14 REVERSIBLE LIQUID / SOLID PHASE CHANGE AND USE THEREOF

Country Status (1)

Country Link
DK (1) DK157033C (en)

Also Published As

Publication number Publication date
DK157033C (en) 1990-04-02
DK455882A (en) 1984-04-15

Similar Documents

Publication Publication Date Title
EP0063348B2 (en) Reversible phase change compositions of calcium chloride hexahydrate with other chlorides
Lane Phase change materials for energy storage nucleation to prevent supercooling
US4637888A (en) Reversible phase change composition for storing energy
DK164112B (en) REVERSIBLE PHASE CHANGE MATERIALS FOR STORING THERMAL ENERGY
US4412931A (en) Reversible phase change compositions of calcium chloride hexahydrate with a potassium salt
JP2529974B2 (en) Reversible Phase Change Composition of Hydrated Calcium Bromide
WO1991000324A1 (en) Calcium chloride hexahydrate formulations for low temperature heat storage applications
CA1243195A (en) Reversible phase change composition for storing energy
US4556501A (en) Heat storage composition
DK157033B (en) Reversible liquid/solid phase change agent and application thereof
NO159178B (en) REVERSIBLE LIQUID / SOLID PHASE CHANGE MATERIAL AND USE THEREOF.
CN112175582A (en) Oxalic acid dihydrate/alum salt eutectic phase-change material and preparation method thereof
NZ202168A (en) Reversible liquid/solid phase change composition:heat storage device
EP0807150B1 (en) Reversible hydrated magnesium chloride phase change compositions for storing energy
JPH0422198B2 (en)
JPS6035076A (en) Reversible phase transfer composition of calcium chloride hexahydrate and potassium chloride
AU640154B2 (en) Calcium chloride hexahydrate formulations for low temperature heat storage applications
JPS58183784A (en) Heat-storing material
Vaccarino et al. Low temperature latent heat storage with quasi-eutectic mixtures containing Ca (NO3) 2• 4H2O
JPH0680957A (en) Heat storage composition
JPH0579714B2 (en)
JPS58117277A (en) Thermal energy storage material
JPH0140077B2 (en)
JPH0134476B2 (en)

Legal Events

Date Code Title Description
PBP Patent lapsed